|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor H.B. 1287
|
|
|
|
|
|
|
|
|
Article - Health — General
Section 21-2A-01 through 21-2A-09, inclusive, to be under the new subtitle
"Subtitle 2A. Prescription Drug Monitoring Program"
Annotated Code of Maryland
(2005 Replacement Volume and 2005 Supplement)
Preamble
WHEREAS, Thousands of Marylanders suffer from chronic pain and other
conditions that make access to pain medications and other pharmaceutical therapies
necessary and beneficial; and
WHEREAS, Increasing numbers of Maryland adults and adolescents are
engaging in prescription drug abuse and diversion to the detriment of their health
and welfare; and
WHEREAS, Maryland should have a Prescription Drug Monitoring Program
that supports the lawful use of controlled substances without interfering with
legitimate professional practice and patient care; and
WHEREAS, A Prescription Drug Monitoring Program should assist health care
professionals and law enforcement professionals in the identification, treatment, and
prevention of prescription drug abuse and in the identification and investigation of
unlawful prescription drug diversion; and
WHEREAS, Data concerning monitored prescription drugs under a Prescription
Drug Monitoring Program would be available for research purposes, including
research about the effects of the Prescription Drug Monitoring Program itself; now,
therefore,
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF
MARYLAND, That the Laws of Maryland read as follows:
Article - Health - General
SUBTITLE 2A. PRESCRIPTION DRUG MONITORING PROGRAM.
21-2A-01.
(A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE THE MEANINGS
INDICATED.
(B) "AUTHORIZED RECIPIENT" MEANS:
(1) A DISPENSER;
(2) A PRESCRIBER;
(3) A FEDERAL LAW ENFORCEMENT AGENCY;
(4) A STATE OR LOCAL LAW ENFORCEMENT AGENCY;
(5) A LICENSING ENTITY;
- 3821 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
